[August 22, 2017] |
|
Colorado BioScience Association, Senator Michael Bennet Host U.S. Food and Drug Administration Commissioner, Dr. Scott Gottlieb, for Life Science Industry Roundtable
Colorado
BioScience Association (CBSA) and Senator Michael Bennet introduced
the new U.S. FDA Commissioner, Dr. Scott Gottlieb, to Colorado's
inventive life science sector today. CBSA and Senator Bennet co-hosted a
roundtable discussion at the University of Colorado Anschutz Medical
Campus covering topics including clinical trials, Breakthrough Therapy
Designation, precision and regenerative medicine, the regulatory
landscape for diagnostics, the digital health regulatory action plan,
and the implementation of the 21st Century Cures and MEDTECH
acts with the Commissioner, who was appointed in May.
More than 60 of the state's life science innovators, including CEOs,
academic leaders and researchers shared their views on progress and the
future outlook for the industry in Colorado at this morning's roundtable
discussion, held at University of Colorado Anschutz Medical Campus in
Aurora.
April Giles, President and CEO of CBSA says: "It's an honor
for CBSA to co-host Dr. Gottlieb with Senator Bennet and introduce him
to the dynamic industry leaders in our state. His visit to Colorado
highlights our state's pioneering role in developing new cures and
solving health care challenges. We also appreciate Senator Bennet's
leadership and the strong partnership hes built with the FDA."
Michael Bennet, U.S. Senator for Colorado says: "Colorado is
home to one of the fastest growing bioscience sectors, leading the way
on life-changing research and development. Dr. Gottlieb's visit was an
opportunity for researchers and innovators to engage with the FDA's
leading voice in Washington. We look forward to continuing our work
together to ensure lifesaving treatments make it to patients quickly and
safely."
Don Elliman, Chancellor, University of Colorado Anschutz Medical
Campus says: "We're happy to host Senator Bennet and
Commissioner Gottlieb at the University of Colorado Anschutz Medical
Campus, where we are pioneering bioscience collaboration every day. The
evolving health care landscape requires new models for innovation, and
CU Anschutz is creating them. On our campus, the collaboration of the
bioscience industry with our researchers and clinicians enables concepts
to move from the research stage into practice, yielding breakthroughs in
bioscience and real-world impacts on health care."
Participants in the roundtable represented the state's thriving life
science sector, with more than 720 companies and institutions that
support 159,000 bioscience-related jobs. CBSA members taking part in
today's discussion highlighted diversity and innovation in CBSA's
350-strong member base.
The Anschutz Medical Campus and adjoining Fitzsimons Innovation Campus
Bioscience Park Center are home to several of the state's leading life
science companies, research hospitals and institutions. The Anschutz
Campus is recognized as one of the nation's leading medical complexes.
About the Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the
hub of Colorado's thriving bioscience sector by connecting innovators to
funding, infrastructure, research and talent. From promising young
companies to established corporations and institutions, we provide
opportunities for networking, education and professional development. We
grow the bioscience workforce and lead business expansion policies to
advance the industry in our state. CBSA represents more than 350 member
organizations, including biotechnology, pharmaceutical, medical device,
diagnostic, ag bio and mobile digital health companies, research and
academic institutions and service providers. Learn more about us at http://www.cobioscience.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170822006213/en/
[ Back To Mobile World Congress's Homepage ]
|